Detalhe da pesquisa
1.
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
Clin Infect Dis
; 76(8): 1412-1422, 2023 04 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36482216
2.
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial.
Antimicrob Agents Chemother
; 65(8): e0014021, 2021 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33972248
3.
High resolution imaging and five-year tuberculosis contact outcomes.
medRxiv
; 2023 Jul 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37461515
4.
Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.
J Clin Invest
; 131(12)2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33945513
5.
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].
Wellcome Open Res
; 6: 136, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34286103